Data coverage, completeness and provenance for ZELIRA THERAPEUTICS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-02-27T04:55:35. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.5000 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.5000 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.5000 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.5000 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.5000 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/ZLD/prices · Price parameters and adjustment semantics
Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops ZENIVOL, a cannabinoid drug for the treatment of chronic insomnia. The company also provides over the counter (OTC) products, including SprinJeneCBD, an oral care product; and acne treatment products under the RAF FIVE name, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. In addition, it offers products for autism and chronic noncancer pain. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is based in Perth, Australia.
Website: https://zeliratx.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2025), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/ZLD/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (AUD) | 2025-06-30 | 29 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 30 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 30 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 30 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/ZLD
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/ZLD/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/ZLD/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/ZLD/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/ZLD/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/ZLD
Free tier — instant API key. Built for AI agents.